Park Avenue Securities LLC Gilead Sciences, Inc. Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 21,875 shares of GILD stock, worth $1.93 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,875

Previous 28,008 21.9%

Holding current value

$1.93 Million

Previous $1.92 Million 4.58%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$66.59 - $83.99 $408,396 - $515,110	-6,133 Reduced 21.9%	21,875 $1.83 Million
Q2 2024 Jul 09, 2024	SELL	$63.15 - $72.88 $469,393 - $541,717	-7,433 Reduced 20.97%	28,008 $1.92 Million
Q1 2024 Apr 10, 2024	SELL	$71.58 - $87.29 $2.07 Million - $2.53 Million	-28,964 Reduced 44.97%	35,441 $2.6 Million
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $591,948 - $671,284	8,079 Added 14.34%	64,405 $5.22 Million
Q3 2023 Oct 26, 2023	BUY	$73.94 - $80.67 $401,937 - $438,522	5,436 Added 10.68%	56,326 $4.22 Million
Q2 2023 Jul 14, 2023	BUY	$76.01 - $86.7 $204,010 - $232,702	2,684 Added 5.57%	50,890 $3.92 Million
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $226,827 - $258,426	-2,934 Reduced 5.74%	48,206 $4 Million
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $766,722 - $1.1 Million	12,303 Added 31.68%	51,140 $0
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $489,478 - $559,110	8,221 Added 26.85%	38,837 $2.4 Million
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $848,137 - $955,256	14,694 Added 92.29%	30,616 $1.89 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $128,119 - $160,546	2,212 Added 16.13%	15,922 $947,000
Q4 2021 Apr 08, 2022	BUY	$64.88 - $73.64 $93,297 - $105,894	1,438 Added 11.72%	13,710 $995,000
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $21,863 - $23,588	323 Added 2.7%	12,272 $857,000
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $63,533 - $69,419	1,001 Added 9.14%	11,949 $823,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $127,800 - $145,819	2,130 Added 24.16%	10,948 $708,000
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $3,115 - $3,550	-55 Reduced 0.62%	8,818 $514,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $12,482 - $15,694	-201 Reduced 2.22%	8,873 $561,000
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $656,413 - $762,216	9,074 New	9,074 $698,000
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $607,698 - $778,374	-9,703 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $23,415 - $25,756	380 Added 4.08%	9,703 $631,000
Q3 2019 Oct 18, 2019	BUY	$62.51 - $69.0 $582,780 - $643,287	9,323 New	9,323 $591,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $199,345 - $223,542	-3,222 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $201,471 - $225,701	3,222 New	3,222 $212,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Gilead Sciences, Inc. Transaction History